Mark For: ORNA™ trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88827351 |
Mark Literal Elements | ORNA |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK. SERVICE MARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2020-09-01 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Jessica L. Rothstein |
Attorney Docket Number | 141736297050 |
2020-03-09 | Application Filed |
2020-03-12 | Location: NEW APPLICATION PROCESSING |
2020-03-12 | Status: Live/Pending |
2020-03-12 | Transaction Date |
2020-07-07 | Published |
2020-09-01 | Location: INTENT TO USE SECTION |
2021-03-12 | Status: A first request for extension of time to file a Statement of Use has been granted. |
Party: | ![]() |
Address | 620 Memorial Drive Cambridge, MASSACHUSETTS UNITED STATES 02139 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Party: | ![]() |
Address | 450 Kendall Street Cambridge, MASSACHUSETTS UNITED STATES 02142 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | MULTI | 2020-03-09 |
![]() | JPEG | 2020-03-09 |
![]() | XML | 2020-05-28 |
![]() | MULTI | 2020-05-29 |
![]() | XML | 2020-06-17 |
![]() | XML | 2020-06-17 |
![]() | APPLICATION/XML | 2020-07-07 |
![]() | APPLICATION/XML | 2020-09-01 |
![]() | MULTI | 2021-02-23 |
![]() | APPLICATION/XML | 2021-03-13 |
![]() | MULTI | 2021-03-13 |
![]() | XML | 2021-04-15 |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders, a full line of nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics
IC 042. US 100 101. G & S: Scientific research in the fields of nucleic acid pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders, a full line of nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics |
GS0051 | Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the treatment of cancer, autoimmune, immune mediated, immune system related, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the prevention and treatment of viral and infectious diseases; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for therapeutic vaccines |
Description | Date |
---|---|
![]() | 2021-02-17 |
Description | Date | Proceeding Number |
---|---|---|
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-04-15 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-04-15 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-04-15 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-04-15 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-04-15 | 88888 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-03-13 | |
EXTENSION 1 GRANTED | 2021-03-12 | 70565 |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-03-10 | 70565 |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2021-02-24 | |
TEAS EXTENSION RECEIVED | 2021-02-23 | |
EXTENSION 1 FILED | 2021-02-23 | 70565 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-09-01 | |
PUBLISHED FOR OPPOSITION | 2020-07-07 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-07-07 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-06-17 | |
ASSIGNED TO EXAMINER | 2020-05-28 | 73359 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-05-28 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-03-14 | |
NEW APPLICATION ENTERED IN TRAM | 2020-03-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.